DNA & Genetics uniQure Shares Reach Five-Year High on “Game Changing” Huntington’s DataBy adminSeptember 28, 20250 The dazzling 36-month clinical data announced by uniQure (NASDAQ: QURE) showing a significant slowing of Huntington’s disease (HD) progression in…
Gut Health Huntington’s disease: new gene therapy explainedBy adminSeptember 27, 20250 A gene therapy trial claims to show promising results for patients with Huntington’s disease. A press announcement of the experimental…
Gut Health Huntington’s disease treated for first time using gene therapyBy adminSeptember 25, 20250 A brain scan of a person with Huntington’s disease, which causes a loss of brain volume as neurons are killed…
Longevity Gene therapy slows Huntington’s by 75 percentBy adminSeptember 25, 20250 Study highlights functional preservation in patients and signals the potential for pre-symptomatic intervention. For decades Huntington’s disease has stood as…
